Iodide

Iodide

SCHEMBL8553864

Cc1cccc2ccc[n+](C)c12.[I-]

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE known ✓ P22303 2/20 0.38
KMT2A Q03164 3/20 0.57
KDM4E B2RXH2 3/20 0.57
NSD2 O96028 2/20 0.57
POLB P06746 2/20 0.57
MAPT P10636 2/20 0.57
THRB P10828 2/20 0.57
RECQL P46063 2/20 0.57
GALK1 P51570 2/20 0.57
BLM P54132 2/20 0.57
L3MBTL1 Q9Y468 2/20 0.57
TDP2 O95551 1/20 0.57
TDP1 Q9NUW8 1/20 0.57
CYP2A6 P11509 3/20 0.38
ALDH1A1 P00352 2/20 0.38
MEN1 O00255 1/20 0.38
PABPC1 P11940 1/20 0.38
RAB9A P51151 1/20 0.38
HTT P42858 1/20 0.36
APAF1 O14727 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13416100 0.98 KMT2A (0.59) KMT2AKDM4ENSD2POLBMAPT
Iodide SCHEMBL9354197 0.77 THRB (0.55) KMT2AKDM4ENSD2POLBMAPT
SCHEMBL11071203 0.75 MAPT (0.42) KMT2AKDM4ENSD2POLBMAPT
SCHEMBL9288975 0.74 THRB (0.57) KMT2AKDM4ENSD2POLBMAPT
SCHEMBL2133978 0.74 CYP2A6 (0.43) KMT2AKDM4ENSD2POLBMAPT
SCHEMBL19122391 0.71 CYP1A2 (0.46) KMT2AKDM4ENSD2POLBMAPT
SCHEMBL18434530 0.71 KDM4E (0.53) KMT2AKDM4ENSD2POLBMAPT
SCHEMBL22310963 0.70 TDP1 (0.52) KMT2AKDM4ENSD2POLBMAPT
SCHEMBL1426045 0.69 THRB (0.56) KMT2AKDM4ENSD2POLBMAPT
SCHEMBL2495381 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0623614-B1 4-Aryl-4-hydroxy-tetrahydropyrans and 3-aryl-3-hydroxy-tetrahydrofurans as 5-lipoxygenase inhibitors ZENECA LTD (GB) 1998-02-25 EP disclosed
US-5512594-A ADMINISTERING TO TREAT A MEDICAL CONDITION MEDIATED BY ONE OR MORE LEUKOTRIENES ZENECA LIMITED (GB) 1996-04-30 US disclosed
US-5478842-A Antiinflammatory agents, antiallergens, drugs for treatment of diseases mediated by leukotrienes ZENECA LIMITED (GB) 1995-12-26 US disclosed
WO-1994025453-A1 4-ARYL-4-HYDROXY-TETRAHYDROPYRANS AND 3-ARYL-3-HYDROXY-TETRAHYDROFURANS AS 5-LIPOXYGENASE INHIBITORS ZENECA LIMITED (GB) 1994-11-10 WO disclosed
EP-0623614-A1 4-Aryl-4-hydroxy-tetrahydropyrans and 3-aryl-3-hydroxy-tetrahydrofurans as 5-lipoxygenase inhibitors ZENECA LIMITED (GB) 1994-11-09 EP disclosed